CIK 0001116463
- Accelerated filer
ORASURE TECHNOLOGIES INC
Sign in to watch- Ticker
- OSUR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364370966
- Phone
- +1 503-641-6115
- Business address
- 220 E FIRST ST, BETHLEHEM, PA, 18015
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-06 | Patrick Charles W Director | Shares withheld for taxes | −1,980 | $9.88 | $20K | 50,054 |
| 2019-05-06 | SARIN ARADHANA Director | Shares withheld for taxes | −1,661 | $9.88 | $16K | 4,483 |
| 2019-05-06 | HOBBS EAMONN P Director | Shares withheld for taxes | −1,351 | $9.88 | $13K | 18,120 |
| 2019-05-06 | LANCASTER RONNY B Director | Shares withheld for taxes | −1,873 | $9.88 | $19K | 8,647 |
| 2019-04-18 | REED MICHAEL SVP R&D and CSO | Shares withheld for taxes | −2,674 | $9.55 | $26K | 49,217 |
| 2019-04-01 | TANG STEPHEN S PHD President and CEO | Exercise or conversion | +16,667 | $8.33 | $139K | 135,627 |
| 2019-04-01 | TANG STEPHEN S PHD President and CEO | Sale | −16,667 | $11.10 | $185K | 118,960 |
| 2019-04-01 | TANG STEPHEN S PHD President and CEO | Exercise or conversion · Option (right to buy) | −16,667 | 0 | ||
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Shares withheld for taxes | −5,371 | $12.98 | $70K | 143,012 |
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Shares withheld for taxes | −3,400 | $12.98 | $44K | 139,612 |
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Shares withheld for taxes | −1,505 | $12.98 | $20K | 138,107 |
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Grant or award | +19,667 | 157,774 | ||
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Grant or award | +24,135 | $12.98 | $313K | 181,909 |
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Shares withheld for taxes | −11,217 | $12.98 | $146K | 170,692 |
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Grant or award | +24,135 | $12.98 | $313K | 194,827 |
| 2019-02-01 | Zezzo II Anthony EVP & BU Lead - Infectious | Shares withheld for taxes | −11,217 | $12.98 | $146K | 183,610 |
| 2019-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −2,985 | $12.98 | $39K | 23,189 |
| 2019-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −1,260 | $12.98 | $16K | 21,929 |
| 2019-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Shares withheld for taxes | −760 | $12.98 | $10K | 21,169 |
| 2019-02-01 | Weber Kathleen Gallagher EVP & BU Lead - Molecular | Grant or award | +13,028 | 34,197 |
Page 18 of 35 · 697 trades